One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2021-153146
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 27 |
Affiliation: Southeast Clinical Oncology Research Consortium, National Cancer Institute, University of Chicago, Washington University in St. Louis, The Ohio State University, Mayo Clinic, Dana-Farber Cancer Institute, Stanford University, FWRadiology, Duke Medical Center, University of Rochester, University of Calgary, University of Cincinnati Medical Center, Alliance Data (United States), Loyola University Medical Center, Massachusetts General Hospital, University of Alabama at BirminghamLong-Term Results of Alliance A041202 Show Continued Advantage of Ibrutinib-Based Regimens Compared with Bendamustine Plus Rituximab (BR) Chemoimmunotherapy
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
